Factor I Autoantibodies in Patients with Atypical Hemolytic Uremic Syndrome: Disease-Associated or an Epiphenomenon? (original) (raw)

aHUS caused by complement dysregulation: new therapies on the horizon

Pediatric Nephrology, 2010

Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome

Kidney International, 2010

Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I

Anna Blom

European Journal of Immunology, 2009

View PDFchevron_right

Mutations in Proteins of the Alternative Pathway of Complement and the Pathogenesis of Atypical Hemolytic Uremic Syndrome

Margarita López Trascasa

American Journal of Kidney Diseases, 2008

View PDFchevron_right

Mutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome

David Kavanagh

Journal of the American Society of Nephrology, 2005

View PDFchevron_right

The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome

M.-a. Dragon-durey

Journal of Medical Genetics, 2009

View PDFchevron_right

Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene

Katherine Vernon

Journal of Human Genetics, 2012

View PDFchevron_right

Alternative complement pathway assessment in patients with atypical HUS

Marie-Agnès Dragon-Durey

Journal of Immunological Methods, 2011

View PDFchevron_right

Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome

vincent durey

2008

View PDFchevron_right

Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome

Christine Skerka

2007

View PDFchevron_right

Functional mapping of the interactions between complement C3 and regulatory proteins using atypical hemolytic uremic syndrome-associated mutations

Richard Smith

Blood, 2015

View PDFchevron_right

Evaluation of complement regulatory components in patients with atypical hemolytic uremic syndrome

Akbar Dorgalaleh

Central European Journal of Immunology, 2014

View PDFchevron_right

Deletion of Complement Factor H Related Genes CFHR1 and CFHR3 is Associated with an Increased Risk of Atypical Hemolytic Uremic Syndrome

anne hughes

PLoS Genetics, 2005

View PDFchevron_right

Atypical Hemolytic Uremic Syndrome Associated with Mutations in Complement Regulator Genes

Marina Noris

Seminars in Thrombosis and Hemostasis, 2010

View PDFchevron_right

Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome

Leana Wen, Guido Filler, Salih Kavukçu, Ronny Decorte

Proceedings of the National Academy of Sciences, 2003

View PDFchevron_right

Complement and the atypical hemolytic uremic syndrome in children

Marina Noris

Pediatric Nephrology, 2008

View PDFchevron_right

Screening for Complement System Abnormalities in Patients with Atypical Hemolytic Uremic Syndrome

Marina Noris

Clinical Journal of the American Society of Nephrology, 2007

View PDFchevron_right

Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS

Marina Noris

Frontiers in Immunology

View PDFchevron_right

Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome

Christophe Hue

View PDFchevron_right

Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome

Bryan Rodriguez

Proceedings of the National Academy of Sciences, 2006

View PDFchevron_right

Reinhard Wallich

Blood, 2009

View PDFchevron_right

Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome

Veli-Pekka Jaakola

The EMBO Journal, 2006

View PDFchevron_right

Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains

Ruben Barricarte, S. Recalde

Journal of Experimental Medicine, 2007

View PDFchevron_right

The Alternative Pathway of Complement and the Evolving Clinical-Pathophysiological Spectrum of Atypical Hemolytic Uremic Syndrome

Bruce Berger

The American journal of the medical sciences, 2016

View PDFchevron_right

A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H-Related 3 Gene in Atypical Hemolytic Uremic Syndrome

Atif Awan

Journal of the American Society of Nephrology : JASN, 2015

View PDFchevron_right

Hemolytic Uremic Syndrome: A Factor H Mutation (E1172Stop) Causes Defective Complement Control at the Surface of Endothelial Cells

Marina Noris

Journal of the American Society of Nephrology, 2007

View PDFchevron_right

Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome

Antonia Bouts

Pediatric nephrology (Berlin, Germany), 2016

View PDFchevron_right

The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome

Margarita López Trascasa

Molecular Immunology, 2015

View PDFchevron_right

De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome

Pierre Robitaille

Human Mutation, 2006

View PDFchevron_right

Diagnosis of complement alternative pathway disorders

Antonello Pani

Kidney international, 2016

View PDFchevron_right

Factor I Autoantibodies in Patients with Atypical Hemolytic Uremic Syndrome: Disease-Associated or an Epiphenomenon? (original) (raw)

Related papers